A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

Clinical trial NCT06649110 · RECRUITING

Trial details

NCT number: NCT06649110
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers, Pulmonary Arterial Hypertension

Start date: 2024-10-24
Primary completion: 2028-11-29
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.